Cite
APA Citation
Buonomo, A. R., Zappulo, E., Viceconte, G., Scotto, R., Borgia, G., & Gentile, I. (2018). risk of opportunistic infections in patients treated with alemtuzumab for multiple sclerosis. Expert opinion on drug safety, 17(7), 709–717. http://access.bl.uk/ark:/81055/vdc_100066523420.0x000025